These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17595427)

  • 21. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
    Seltzer B
    J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical benefits of a new piperidine-class AChE inhibitor.
    Doody RS
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
    Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
    Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses to donepezil in Alzheimer's disease and Parkinson's disease.
    Mori S
    Ann N Y Acad Sci; 2002 Nov; 977():493-500. PubMed ID: 12480791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility.
    Tariot PN; Jakimovich L
    J Am Med Dir Assoc; 2003; 4(4):216-9. PubMed ID: 12837144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacotherapy for Alzheimer's disease].
    Verhey FR
    Tijdschr Psychiatr; 2006; 48(1):17-26. PubMed ID: 16955982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of Alzheimer's disease: clinicians's lecture].
    Joray S; Ghika J; von Gunten A; Büla C; Gold G; Assal F
    Rev Med Suisse; 2006 Jan; 2(50):307. PubMed ID: 16503050
    [No Abstract]   [Full Text] [Related]  

  • 30. [Doubtful evidence for the use of the cholinesterase inhibitor donepezil in patients with dementia--a systematic review].
    Kaduszkiewicz H; Beck-Bornholdt HP; van den Bussche H; Zimmermann T
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):557-63. PubMed ID: 15472779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: the benefits of early treatment.
    Gauthier SG
    Eur J Neurol; 2005 Oct; 12 Suppl 3():11-6. PubMed ID: 16144532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW; Soininen H; Hager K; Aarsland D; Passmore P; Murthy A; Zhang R; Bahra R
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 34. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained cognitive improvement following treatment of Alzheimer's disease with donepezil.
    Evans M; Ellis A; Watson D; Chowdhury T
    Int J Geriatr Psychiatry; 2000 Jan; 15(1):50-3. PubMed ID: 10637404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
    Sugimoto H
    Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AD2000: design and conclusions.
    Clarke N
    Lancet; 2004 Oct 2-8; 364(9441):1215-6; author reply 1216-7. PubMed ID: 15464176
    [No Abstract]   [Full Text] [Related]  

  • 38. AD2000: design and conclusions.
    Howe I
    Lancet; 2004 Oct 2-8; 364(9441):1214-5; author reply 1216-7. PubMed ID: 15464174
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease.
    Reeves RR; Struve FA; Patrick G; Booker JG; Nave DW
    Am J Geriatr Psychiatry; 1999; 7(4):349-52. PubMed ID: 10521169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.